PlainPharmaWatch

CMS Open Payments · Program Year 2024

Ovesco Endoscopy USA, Inc.

Ovesco Endoscopy USA, Inc. reported $60,991.83 across General Payments, Research, and Ownership to 62 physicians and teaching hospitals across 62 transactions.

See the rankings → How this is sourced
$61.0K
All-tracks total
62
Transactions
62
Recipients
+$12.8K
General Payments vs PY2023

Ovesco Endoscopy USA, Inc. reported $60,991.83 across all CMS Open Payments tracks (General + Research + Ownership) to 62 physicians and teaching hospitals in Program Year 2024 - ranking #1304 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $60,991.83, averaging $983.74 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer ovesco-endoscopy-usa-inc Ovesco Endoscopy USA, Inc.

$61.0K · #1304/1,925 · 0.0% industry · PY2024

  • TOT $61.0K
  • RANK #1304
  • SHARE 0.0%
  • TXN 62
  • RCP 62
  • CAT 3
  • GEN $61.0K
  • ΔGEN +$12.8K
  • TOP1 11.7%
  • PY 2024

Volume peers

Nearest volume peer: Lenoss Medical Inc ($61.1K)

Forma Medical$61.1KLenoss Medical Inc$61.1KOvesco Endoscopy USA, Inc. (…$61.0KVertical Pharmaceuticals, LLC$60.9KPerrigo Company plc$60.8K
All-tracks payment totals near Ovesco Endoscopy USA, Inc. (CMS Open Payments PY2024)

Ovesco Endoscopy USA, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Ovesco Endoscopy USA, Inc.'s CMS-reported General Payments increased by $12.8K (+26.5%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2023: OVESCO ENDOSCOPY USA, INC.PY2024: Ovesco Endoscopy USA, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$48.2KPY2024$61.0K
PY2023
$48,223.20
PY2024
$60,991.83

What the Data Shows for Ovesco Endoscopy USA, Inc.

$60,991.83: that is what Ovesco Endoscopy USA, Inc. reported in payments to 62 physicians and teaching hospitals during Program Year 2024, spread across 62 transactions ($983.74 per transaction, $983.74 per recipient). The company sits at rank #1304 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Travel and Lodging" at $41.6K, accounting for 68.2% of this company's General Payments and 52 transactions.

General Payment Breakdown by Type

Ovesco Endoscopy USA, Inc. made 3 types of general payments. "Travel and Lodging" is the largest category at $41.6K, 68.2% of General Payments.

How Ovesco Endoscopy USA, Inc. divides its payments

Top payment categories by total reported dollar volume

1. Travel and Lodging$41.6K2. Consulting Fee$19.2K3. Food and Beverage$153.63
Payment Type Amount Transactions
Travel and Lodging $41.6K 52
Consulting Fee $19.2K 9
Food and Beverage $153.63 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $21,804.42 (35.7%) of $60,991.83 in this company's General Payments records across 56 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Ovesco Endoscopy USA, Inc.

The five named recipients with the highest reported General Payments from this company

Jianhua Tau$7.1KPhillip Ge$4.7KBhavesh Shah$4.7KJerome Edelson$2.8KJason Samarasena$2.5K
  1. 1

    Jianhua Tau

    $7,120.16 across 1 reported transactions

  2. 2

    Phillip Ge

    $4,725.00 across 5 reported transactions

  3. 3

    Bhavesh Shah

    $4,676.75 across 1 reported transactions

  4. 4

    Jerome Edelson

    $2,832.51 across 3 reported transactions

  5. 5

    Jason Samarasena

    $2,450.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Ovesco Endoscopy USA, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Ovesco Endoscopy USA, Inc..

Medela LLC

HHI 384

Augmedics Inc.

HHI 383

Impulse Dynamics (USA) Inc.

HHI 385

Breg, Inc

HHI 385

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Ovesco Endoscopy USA, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Ovesco Endoscopy USA, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.